Table of Contents 1 Market Overview 1.1 Preventive Asthma Drug Introduction 1.2 Market Analysis by Type 1.2.1 Somatostatin Analogs 1.2.2 Targeted Therapy 1.2.3 Chemotherapy 1.3 Market Analysis by Applications 1.3.1 Hospital 1.3.2 Clinics 1.3.3 Oncology Centres 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Xiaflex 2.1.1 Business Overview 2.1.1.1 Xiaflex Description 2.1.1.2 Xiaflex Headquarter, Main Business and Finance Overview 2.1.2 Xiaflex Preventive Asthma Drug Product Introduction 2.1.2.1 Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors 2.1.2.2 Preventive Asthma Drug Product Information 2.1.3 Xiaflex Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.1 Xiaflex Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.2 Global Xiaflex Preventive Asthma Drug Market Share in 2017 2.2 Novartis AG 2.2.1 Business Overview 2.2.1.1 Novartis AG Description 2.2.1.2 Novartis AG Headquarter, Main Business and Finance Overview 2.2.2 Novartis AG Preventive Asthma Drug Product Introduction 2.2.2.1 Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors 2.2.2.2 Preventive Asthma Drug Product Information 2.2.3 Novartis AG Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.1 Novartis AG Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.2 Global Novartis AG Preventive Asthma Drug Market Share in 2017 2.3 Roche 2.3.1 Business Overview 2.3.1.1 Roche Description 2.3.1.2 Roche Headquarter, Main Business and Finance Overview 2.3.2 Roche Preventive Asthma Drug Product Introduction 2.3.2.1 Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors 2.3.2.2 Preventive Asthma Drug Product Information 2.3.3 Roche Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.1 Roche Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.2 Global Roche Preventive Asthma Drug Market Share in 2017 2.4 Molecular Insight Pharmaceuticals 2.4.1 Business Overview 2.4.1.1 Molecular Insight Pharmaceuticals Description 2.4.1.2 Molecular Insight Pharmaceuticals Headquarter, Main Business and Finance Overview 2.4.2 Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Introduction 2.4.2.1 Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors 2.4.2.2 Preventive Asthma Drug Product Information 2.4.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.1 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.2 Global Molecular Insight Pharmaceuticals Preventive Asthma Drug Market Share in 2017 2.5 Callisto Pharmaceuticals 2.5.1 Business Overview 2.5.1.1 Callisto Pharmaceuticals Description 2.5.1.2 Callisto Pharmaceuticals Headquarter, Main Business and Finance Overview 2.5.2 Callisto Pharmaceuticals Preventive Asthma Drug Product Introduction 2.5.2.1 Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors 2.5.2.2 Preventive Asthma Drug Product Information 2.5.3 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.1 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.2 Global Callisto Pharmaceuticals Preventive Asthma Drug Market Share in 2017 3 Global Preventive Asthma Drug Market Competition, by Manufacturer 3.1 Global Preventive Asthma Drug Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Preventive Asthma Drug Revenue and Market Share by Manufacturer (2016-2017) 3.3 Global Preventive Asthma Drug Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Preventive Asthma Drug Manufacturer Market Share in 2017 3.4.2 Top 5 Preventive Asthma Drug Manufacturer Market Share in 2017 3.5 Market Competition Trend 4 Global Preventive Asthma Drug Market Analysis by Regions 4.1 Global Preventive Asthma Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Preventive Asthma Drug Sales by Regions (2013-2018) 4.1.2 Global Preventive Asthma Drug Revenue by Regions (2013-2018) 4.2 North America Preventive Asthma Drug Sales, Revenue and Growth Rate (2013-2018) 4.3 Europe Preventive Asthma Drug Sales, Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Preventive Asthma Drug Sales, Revenue and Growth Rate (2013-2018) 4.5 South America Preventive Asthma Drug Sales, Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Preventive Asthma Drug Sales, Revenue and Growth Rate (2013-2018) 5 North America Preventive Asthma Drug by Countries, Type, Application and Manufacturers 5.1 North America Preventive Asthma Drug Sales, Revenue and Market Share by Countries 5.1.1 North America Preventive Asthma Drug Sales by Countries (2013-2018) 5.1.2 North America Preventive Asthma Drug Revenue by Countries (2013-2018) 5.1.3 United States Preventive Asthma Drug Sales and Growth Rate (2013-2018) 5.1.4 Canada Preventive Asthma Drug Sales and Growth Rate (2013-2018) 5.1.5 Mexico Preventive Asthma Drug Sales and Growth Rate (2013-2018) 5.2 North America Preventive Asthma Drug Sales and Revenue (Value) by Manufacturers (2016-2017) 5.2.1 North America Preventive Asthma Drug Sales by Manufacturers (2016-2017) 5.2.2 North America Preventive Asthma Drug Revenue by Manufacturers (2016-2017) 5.3 North America Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 5.3.1 North America Preventive Asthma Drug Sales and Sales Share by Type (2013-2018) 5.3.2 North America Preventive Asthma Drug Revenue and Revenue Share by Type (2013-2018) 5.4 North America Preventive Asthma Drug Sales, Revenue and Market Share by Application (2013-2018) 5.4.1 North America Preventive Asthma Drug Sales and Sales Share by Application (2013-2018) 5.4.2 North America Preventive Asthma Drug Revenue and Revenue Share by Application (2013-2018) 6 Europe Preventive Asthma Drug by Countries, Type, Application and Manufacturers 6.1 Europe Preventive Asthma Drug Sales, Revenue and Market Share by Countries 6.1.1 Europe Preventive Asthma Drug Sales by Countries (2013-2018) 6.1.2 Europe Preventive Asthma Drug Revenue by Countries (2013-2018) 6.1.3 Germany Preventive Asthma Drug Sales and Growth Rate (2013-2018) 6.1.4 UK Preventive Asthma Drug Sales and Growth Rate (2013-2018) 6.1.5 France Preventive Asthma Drug Sales and Growth Rate (2013-2018) 6.1.6 Russia Preventive Asthma Drug Sales and Growth Rate (2013-2018) 6.1.7 Italy Preventive Asthma Drug Sales and Growth Rate (2013-2018) 6.2 Europe Preventive Asthma Drug Sales and Revenue (Value) by Manufacturers (2016-2017) 6.2.1 Europe Preventive Asthma Drug Sales by Manufacturers (2016-2017) 6.2.2 Europe Preventive Asthma Drug Revenue by Manufacturers (2016-2017) 6.3 Europe Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 6.3.1 Europe Preventive Asthma Drug Sales and Sales Share by Type (2013-2018) 6.3.2 Europe Preventive Asthma Drug Revenue and Revenue Share by Type (2013-2018) 6.4 Europe Preventive Asthma Drug Sales, Revenue and Market Share by Application (2013-2018) 6.4.1 Europe Preventive Asthma Drug Sales and Sales Share by Application (2013-2018) 6.4.2 Europe Preventive Asthma Drug Revenue and Revenue Share by Application (2013-2018) 7 Asia-Pacific Preventive Asthma Drug by Countries, Type, Application and Manufacturers 7.1 Asia-Pacific Preventive Asthma Drug Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Preventive Asthma Drug Sales by Countries (2013-2018) 7.1.2 Asia-Pacific Preventive Asthma Drug Revenue by Countries (2013-2018) 7.1.3 China Preventive Asthma Drug Sales and Growth Rate (2013-2018) 7.1.4 Japan Preventive Asthma Drug Sales and Growth Rate (2013-2018) 7.1.5 Korea Preventive Asthma Drug Sales and Growth Rate (2013-2018) 7.1.6 India Preventive Asthma Drug Sales and Growth Rate (2013-2018) 7.1.7 Southeast Asia Preventive Asthma Drug Sales and Growth Rate (2013-2018) 7.2 Asia-Pacific Preventive Asthma Drug Sales and Revenue (Value) by Manufacturers (2016-2017) 7.2.1 Asia-Pacific Preventive Asthma Drug Sales by Manufacturers (2016-2017) 7.2.2 Asia-Pacific Preventive Asthma Drug Revenue by Manufacturers (2016-2017) 7.3 Asia-Pacific Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 7.3.1 Asia-Pacific Preventive Asthma Drug Sales and Sales Share by Type (2013-2018) 7.3.2 Asia-Pacific Preventive Asthma Drug Revenue and Revenue Share by Type (2013-2018) 7.4 Asia-Pacific Preventive Asthma Drug Sales, Revenue and Market Share by Application (2013-2018) 7.4.1 Asia-Pacific Preventive Asthma Drug Sales and Sales Share by Application (2013-2018) 7.4.2 Asia-Pacific Preventive Asthma Drug Revenue and Revenue Share by Application (2013-2018) 8 South America Preventive Asthma Drug by Countries, Type, Application and Manufacturers 8.1 South America Preventive Asthma Drug Sales, Revenue and Market Share by Countries 8.1.1 South America Preventive Asthma Drug Sales by Countries (2013-2018) 8.1.2 South America Preventive Asthma Drug Revenue by Countries (2013-2018) 8.1.3 Brazil Preventive Asthma Drug Sales and Growth Rate (2013-2018) 8.1.4 Argentina Preventive Asthma Drug Sales and Growth Rate (2013-2018) 8.1.5 Colombia Preventive Asthma Drug Sales and Growth Rate (2013-2018) 8.2 South America Preventive Asthma Drug Sales and Revenue (Value) by Manufacturers (2016-2017) 8.2.1 South America Preventive Asthma Drug Sales by Manufacturers (2016-2017) 8.2.2 South America Preventive Asthma Drug Revenue by Manufacturers (2016-2017) 8.3 South America Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 8.3.1 South America Preventive Asthma Drug Sales and Sales Share by Type (2013-2018) 8.3.2 South America Preventive Asthma Drug Revenue and Revenue Share by Type (2013-2018) 8.4 South America Preventive Asthma Drug Sales, Revenue and Market Share by Application (2013-2018) 8.4.1 South America Preventive Asthma Drug Sales and Sales Share by Application (2013-2018) 8.4.2 South America Preventive Asthma Drug Revenue and Revenue Share by Application (2013-2018) 9 Middle East and Africa Preventive Asthma Drug by Countries, Type, Application and Manufacturers 9.1 Middle East and Africa Preventive Asthma Drug Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Preventive Asthma Drug Sales by Countries (2013-2018) 9.1.2 Middle East and Africa Preventive Asthma Drug Revenue by Countries (2013-2018) 9.1.3 Saudi Arabia Preventive Asthma Drug Sales and Growth Rate (2013-2018) 9.1.4 UAE Preventive Asthma Drug Sales and Growth Rate (2013-2018) 9.1.5 Egypt Preventive Asthma Drug Sales and Growth Rate (2013-2018) 9.1.6 Nigeria Preventive Asthma Drug Sales and Growth Rate (2013-2018) 9.1.7 South Africa Preventive Asthma Drug Sales and Growth Rate (2013-2018) 9.2 Middle East and Africa Preventive Asthma Drug Sales and Revenue (Value) by Manufacturers (2016-2017) 9.2.1 Middle East and Africa Preventive Asthma Drug Sales by Manufacturers (2016-2017) 9.2.2 Middle East and Africa Preventive Asthma Drug Revenue by Manufacturers (2016-2017) 9.3 Middle East and Africa Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 9.3.1 Middle East and Africa Preventive Asthma Drug Sales and Sales Share by Type (2013-2018) 9.3.1 Middle East and Africa Preventive Asthma Drug Revenue and Revenue Share by Type (2013-2018) 9.4 Middle East and Africa Preventive Asthma Drug Sales, Revenue and Market Share by Application (2013-2018) 9.4.1 Middle East and Africa Preventive Asthma Drug Sales and Sales Share by Application (2013-2018) 9.4.2 Middle East and Africa Preventive Asthma Drug Revenue and Revenue Share by Application (2013-2018) 10 Global Preventive Asthma Drug Market Segment by Type 10.1 Global Preventive Asthma Drug Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Preventive Asthma Drug Sales and Market Share by Type (2013-2018) 10.1.2 Global Preventive Asthma Drug Revenue and Market Share by Type (2013-2018) 10.2 Somatostatin Analogs Sales Growth and Price 10.2.1 Global Somatostatin Analogs Sales Growth (2013-2018) 10.2.2 Global Somatostatin Analogs Price (2013-2018) 10.3 Targeted Therapy Sales Growth and Price 10.3.1 Global Targeted Therapy Sales Growth (2013-2018) 10.3.2 Global Targeted Therapy Price (2013-2018) 10.4 Chemotherapy Sales Growth and Price 10.4.1 Global Chemotherapy Sales Growth (2013-2018) 10.4.2 Global Chemotherapy Price (2013-2018) 11 Global Preventive Asthma Drug Market Segment by Application 11.1 Global Preventive Asthma Drug Sales Market Share by Application (2013-2018) 11.2 Hospital Sales Growth (2013-2018) 11.3 Clinics Sales Growth (2013-2018) 11.4 Oncology Centres Sales Growth (2013-2018) 12 Preventive Asthma Drug Market Forecast (2018-2023) 12.1 Global Preventive Asthma Drug Sales, Revenue and Growth Rate (2018-2023) 12.2 Preventive Asthma Drug Market Forecast by Regions (2018-2023) 12.2.1 North America Preventive Asthma Drug Market Forecast (2018-2023) 12.2.2 Europe Preventive Asthma Drug Market Forecast (2018-2023) 12.2.3 Asia-Pacific Preventive Asthma Drug Market Forecast (2018-2023) 12.2.4 South America Preventive Asthma Drug Market Forecast (2018-2023) 12.2.5 Middle East and Africa Preventive Asthma Drug Market Forecast (2018-2023) 12.3 Preventive Asthma Drug Market Forecast by Type (2018-2023) 12.3.1 Global Preventive Asthma Drug Sales Forecast by Type (2018-2023) 12.3.2 Global Preventive Asthma Drug Market Share Forecast by Type (2018-2023) 12.4 Preventive Asthma Drug Market Forecast by Application (2018-2023) 12.4.1 Global Preventive Asthma Drug Sales Forecast by Application (2018-2023) 12.4.2 Global Preventive Asthma Drug Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Preventive Asthma Drug Picture Table Product Specifications of Preventive Asthma Drug Figure Global Preventive Asthma Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million) Figure Global Preventive Asthma Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales) Figure Global Sales Market Share of Preventive Asthma Drug by Types in 2017 Figure Somatostatin Analogs Picture Table Major Manufacturers of Somatostatin Analogs Figure Targeted Therapy Picture Table Major Manufacturers of Targeted Therapy Figure Chemotherapy Picture Table Major Manufacturers of Chemotherapy Figure Preventive Asthma Drug Sales Market Share by Applications in 2017 Figure Hospital Picture Figure Clinics Picture Figure Oncology Centres Picture Figure United States Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Canada Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Germany Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure France Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure UK Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Russia Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Italy Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure China Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Japan Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Korea Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure India Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Preventive Asthma Drug Revenue (Value) and Growth Rate (2013-2023) Table Xiaflex Headquarter, Established, Main Business and Finance Overview (2017) Table Xiaflex Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors Table Xiaflex Preventive Asthma Drug Product Table Xiaflex Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Xiaflex Preventive Asthma Drug Sales Market Share in 2017 Figure Global Xiaflex Preventive Asthma Drug Revenue Market Share in 2017 Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017) Table Novartis AG Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors Table Novartis AG Preventive Asthma Drug Product Table Novartis AG Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Novartis AG Preventive Asthma Drug Sales Market Share in 2017 Figure Global Novartis AG Preventive Asthma Drug Revenue Market Share in 2017 Table Roche Headquarter, Established, Main Business and Finance Overview (2017) Table Roche Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors Table Roche Preventive Asthma Drug Product Table Roche Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Roche Preventive Asthma Drug Sales Market Share in 2017 Figure Global Roche Preventive Asthma Drug Revenue Market Share in 2017 Table Molecular Insight Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017) Table Molecular Insight Pharmaceuticals Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors Table Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Table Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales Market Share in 2017 Figure Global Molecular Insight Pharmaceuticals Preventive Asthma Drug Revenue Market Share in 2017 Table Callisto Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017) Table Callisto Pharmaceuticals Preventive Asthma Drug Production Bases, Sales Regions and Major Competitors Table Callisto Pharmaceuticals Preventive Asthma Drug Product Table Callisto Pharmaceuticals Preventive Asthma Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Callisto Pharmaceuticals Preventive Asthma Drug Sales Market Share in 2017 Figure Global Callisto Pharmaceuticals Preventive Asthma Drug Revenue Market Share in 2017 Table Global Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure Global Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure Global Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table Global Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure Global Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure Global Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table Global Preventive Asthma Drug Price by Manufacturer (2016-2017) Figure Top 3 Preventive Asthma Drug Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Preventive Asthma Drug Manufacturer (Revenue) Market Share in 2017 Figure Global Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Global Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table Global Preventive Asthma Drug Sales by Regions (2013-2018) Table Global Preventive Asthma Drug Sales Market Share by Regions (2013-2018) Table Global Preventive Asthma Drug Revenue by Regions (2013-2018) Figure Global Preventive Asthma Drug Revenue Market Share by Regions in 2013 Figure Global Preventive Asthma Drug Revenue Market Share by Regions in 2017 Figure North America Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure North America Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Figure Europe Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Europe Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Asia-Pacific Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Figure South America Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure South America Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Middle East and Africa Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Figure North America Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table North America Preventive Asthma Drug Sales by Countries (2013-2018) Table North America Preventive Asthma Drug Sales Market Share by Countries (2013-2018) Figure North America Preventive Asthma Drug Sales Market Share by Countries in 2013 Figure North America Preventive Asthma Drug Sales Market Share by Countries in 2017 Table North America Preventive Asthma Drug Revenue by Countries (2013-2018) Table North America Preventive Asthma Drug Revenue Market Share by Countries (2013-2018) Figure North America Preventive Asthma Drug Revenue Market Share by Countries in 2013 Figure North America Preventive Asthma Drug Revenue Market Share by Countries in 2017 Figure United States Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Canada Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Mexico Preventive Asthma Drug Sales and Growth Rate (2013-2018) Table North America Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure North America Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure North America Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table North America Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure North America Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure North America Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table North America Preventive Asthma Drug Sales by Type (2013-2018) Table North America Preventive Asthma Drug Sales Share by Type (2013-2018) Table North America Preventive Asthma Drug Revenue by Type (2013-2018) Table North America Preventive Asthma Drug Revenue Share by Type (2013-2018) Table North America Preventive Asthma Drug Sales by Application (2013-2018) Table North America Preventive Asthma Drug Sales Share by Application (2013-2018) Table North America Preventive Asthma Drug Revenue by Application (2013-2018) Table North America Preventive Asthma Drug Revenue Share by Application (2013-2018) Figure Europe Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table Europe Preventive Asthma Drug Sales by Countries (2013-2018) Table Europe Preventive Asthma Drug Sales Market Share by Countries (2013-2018) Table Europe Preventive Asthma Drug Revenue by Countries (2013-2018) Figure Europe Preventive Asthma Drug Revenue Market Share by Countries in 2016 Figure Europe Preventive Asthma Drug Revenue Market Share by Countries in 2017 Figure Germany Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure UK Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure France Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Russia Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Italy Preventive Asthma Drug Sales and Growth Rate (2013-2018) Table Europe Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure Europe Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure Europe Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table Europe Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure Europe Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure Europe Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table Europe Preventive Asthma Drug Sales by Type (2013-2018) Table Europe Preventive Asthma Drug Sales Share by Type (2013-2018) Table Europe Preventive Asthma Drug Revenue by Type (2013-2018) Table Europe Preventive Asthma Drug Revenue Share by Type (2013-2018) Table Europe Preventive Asthma Drug Sales by Application (2013-2018) Table Europe Preventive Asthma Drug Sales Share by Application (2013-2018) Table Europe Preventive Asthma Drug Revenue by Application (2013-2018) Table Europe Preventive Asthma Drug Revenue Share by Application (2013-2018) Figure Asia-Pacific Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales by Countries (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Preventive Asthma Drug Sales Market Share by Countries 2017 Table Asia-Pacific Preventive Asthma Drug Revenue by Countries (2013-2018) Figure Asia-Pacific Preventive Asthma Drug Revenue Market Share by Countries 2017 Figure China Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Japan Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Korea Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure India Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Southeast Asia Preventive Asthma Drug Sales and Growth Rate (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure Asia-Pacific Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure Asia-Pacific Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table Asia-Pacific Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure Asia-Pacific Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure Asia-Pacific Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table Asia-Pacific Preventive Asthma Drug Sales by Type (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales Share by Type (2013-2018) Table Asia-Pacific Preventive Asthma Drug Revenue by Type (2013-2018) Table Asia-Pacific Preventive Asthma Drug Revenue Share by Type (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales by Application (2013-2018) Table Asia-Pacific Preventive Asthma Drug Sales Share by Application (2013-2018) Table Asia-Pacific Preventive Asthma Drug Revenue by Application (2013-2018) Table Asia-Pacific Preventive Asthma Drug Revenue Share by Application (2013-2018) Figure South America Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table South America Preventive Asthma Drug Sales by Countries (2013-2018) Table South America Preventive Asthma Drug Sales Market Share by Countries (2013-2018) Figure South America Preventive Asthma Drug Sales Market Share by Countries in 2017 Table South America Preventive Asthma Drug Revenue by Countries (2013-2018) Table South America Preventive Asthma Drug Revenue Market Share by Countries (2013-2018) Figure South America Preventive Asthma Drug Revenue Market Share by Countries in 2017 Figure Brazil Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Argentina Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Colombia Preventive Asthma Drug Sales and Growth Rate (2013-2018) Table South America Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure South America Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure South America Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table South America Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure South America Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure South America Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table South America Preventive Asthma Drug Sales by Type (2013-2018) Table South America Preventive Asthma Drug Sales Share by Type (2013-2018) Table South America Preventive Asthma Drug Revenue by Type (2013-2018) Table South America Preventive Asthma Drug Revenue Share by Type (2013-2018) Table South America Preventive Asthma Drug Sales by Application (2013-2018) Table South America Preventive Asthma Drug Sales Share by Application (2013-2018) Table South America Preventive Asthma Drug Revenue by Application (2013-2018) Table South America Preventive Asthma Drug Revenue Share by Application (2013-2018) Figure Middle East and Africa Preventive Asthma Drug Revenue and Growth Rate (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales by Countries (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Preventive Asthma Drug Sales Market Share by Countries in 2017 Table Middle East and Africa Preventive Asthma Drug Revenue by Countries (2013-2018) Table Middle East and Africa Preventive Asthma Drug Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Preventive Asthma Drug Revenue Market Share by Countries in 2013 Figure Middle East and Africa Preventive Asthma Drug Revenue Market Share by Countries in 2017 Figure Saudi Arabia Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure UAE Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Egypt Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure Nigeria Preventive Asthma Drug Sales and Growth Rate (2013-2018) Figure South Africa Preventive Asthma Drug Sales and Growth Rate (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales by Manufacturer (2016-2017) Figure Middle East and Africa Preventive Asthma Drug Sales Market Share by Manufacturer in 2016 Figure Middle East and Africa Preventive Asthma Drug Sales Market Share by Manufacturer in 2017 Table Middle East and Africa Preventive Asthma Drug Revenue by Manufacturer (2016-2017) Figure Middle East and Africa Preventive Asthma Drug Revenue Market Share by Manufacturer in 2016 Figure Middle East and Africa Preventive Asthma Drug Revenue Market Share by Manufacturer in 2017 Table Middle East and Africa Preventive Asthma Drug Sales by Type (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales Share by Type (2013-2018) Table Middle East and Africa Preventive Asthma Drug Revenue by Type (2013-2018) Table Middle East and Africa Preventive Asthma Drug Revenue Share by Type (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales by Application (2013-2018) Table Middle East and Africa Preventive Asthma Drug Sales Share by Application (2013-2018) Table Middle East and Africa Preventive Asthma Drug Revenue by Application (2013-2018) Table Middle East and Africa Preventive Asthma Drug Revenue Share by Application (2013-2018) Table Global Preventive Asthma Drug Sales by Type (2013-2018) Table Global Preventive Asthma Drug Sales Share by Type (2013-2018) Table Global Preventive Asthma Drug Revenue by Type (2013-2018) Table Global Preventive Asthma Drug Revenue Share by Type (2013-2018) Figure Global Somatostatin Analogs Sales Growth (2013-2018) Figure Global Somatostatin Analogs Price (2013-2018) Figure Global Targeted Therapy Sales Growth (2013-2018) Figure Global Targeted Therapy Price (2013-2018) Figure Global Chemotherapy Sales Growth (2013-2018) Figure Global Chemotherapy Price (2013-2018) Table Global Preventive Asthma Drug Sales by Application (2013-2018) Table Global Preventive Asthma Drug Sales Share by Application (2013-2018) Figure Global Hospital Sales Growth (2013-2018) Figure Global Clinics Sales Growth (2013-2018) Figure Global Oncology Centres Sales Growth (2013-2018) Figure Global Preventive Asthma Drug Sales, Revenue and Growth Rate (2018-2023) Table Global Preventive Asthma Drug Sales Forecast by Regions (2018-2023) Table Global Preventive Asthma Drug Market Share Forecast by Regions (2018-2023) Figure North America Sales Preventive Asthma Drug Market Forecast (2018-2023) Figure Europe Sales Preventive Asthma Drug Market Forecast (2018-2023) Figure Asia-Pacific Sales Preventive Asthma Drug Market Forecast (2018-2023) Figure South America Sales Preventive Asthma Drug Market Forecast (2018-2023) Figure Middle East and Africa Sales Preventive Asthma Drug Market Forecast (2018-2023) Table Global Preventive Asthma Drug Sales Forecast by Type (2018-2023) Table Global Preventive Asthma Drug Market Share Forecast by Type (2018-2023) Table Global Preventive Asthma Drug Sales Forecast by Application (2018-2023) Table Global Preventive Asthma Drug Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Xiaflex Novartis AG Roche Molecular Insight Pharmaceuticals Callisto Pharmaceuticals